Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in neuroprotection trials.

K R Lees1

  • 1University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, UK. k.r.lees@clinmed.gla.ac.uk

European Neurology
|January 11, 2001
PubMed
Summary

Technological advancements can optimize acute stroke trials by improving dose selection, patient eligibility, and data analysis. These methods enhance statistical power and the potential for identifying effective neuroprotective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study.

Journal of internal medicine·2021
Same author

Small vessel disease and clinical outcomes after IV rt-PA treatment.

Acta neurologica Scandinavica·2017
Same author

Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.

The journal of the Royal College of Physicians of Edinburgh·2016
Same author

Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.

European journal of neurology·2016
Same author

Impact of heart rate on admission on mortality and morbidity in acute ischaemic stroke patients - results from VISTA.

European journal of neurology·2016
Same author

Determinants of post-stroke cognitive impairment: analysis from VISTA.

Acta neurologica Scandinavica·2016

Area of Science:

  • Neurology
  • Clinical Trials
  • Biostatistics

Background:

  • Acute stroke research faces challenges in optimizing trial design and statistical analysis.
  • Identifying effective neuroprotective agents requires robust and efficient clinical trial methodologies.

Purpose of the Study:

  • To explore how technological advancements can enhance the design and execution of acute stroke clinical trials.
  • To identify specific strategies for optimizing dose selection, patient eligibility, confounding factor control, and endpoint assessment.

Main Methods:

  • Review of technological applications in clinical trial design.
  • Discussion of adaptive randomization and Bayesian approaches for dose selection and group balancing.
  • Integration of magnetic resonance imaging (MRI) for patient enrichment.
  • Leveraging existing trial databases for advanced statistical analysis.
  • Methods for controlling or adjusting for concomitant conditions.

Main Results:

  • Technological assistance offers significant improvements in various aspects of acute stroke trial design.
  • Adaptive randomization and Bayesian methods aid in dose selection and balancing prognostic factors.
  • MRI facilitates the enrichment of trial populations with likely responders.
  • Utilizing existing databases enhances statistical outcome assessment.
  • Controlling for confounding factors improves trial validity.

Conclusions:

  • Recent acute stroke trials, despite not yet identifying a specific neuroprotectant, have significantly advanced the prospects for future success through improved methodologies.
  • Technological integration is key to optimizing future acute stroke trials and increasing the likelihood of discovering effective treatments.

Related Experiment Videos